The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap
- DOI
- 10.1038/s41573-024-01059-3
- Published
- 2024-11-04
- Container
- Nature Reviews Drug Discovery
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41573-024-01059-3,
title = {The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap},
author = {Anneliene H. Jonker and Elena-Alexandra Tataru and Holm Graessner and David Dimmock and Adam Jaffe and Gareth Baynam and James Davies and Shruti Mitkus and Oxana Iliach and Rich Horgan and Erika F. Augustine and Alison Bateman-House and Anna Maria Gerdina Pasmooij and Tim Yu and Matthis Synofzik and Julie Douville and Larissa Lapteva and Philip John Brooks and Daniel O’Connor and Annemieke Aartsma-Rus and Unknown},
year = {2024},
journal = {Nature Reviews Drug Discovery},
doi = {10.1038/s41573-024-01059-3},
url = {https://doi.org/10.1038/s41573-024-01059-3}
}RIS
TY - JOUR TI - The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap AU - Anneliene H. Jonker AU - Elena-Alexandra Tataru AU - Holm Graessner AU - David Dimmock AU - Adam Jaffe AU - Gareth Baynam AU - James Davies AU - Shruti Mitkus AU - Oxana Iliach AU - Rich Horgan AU - Erika F. Augustine AU - Alison Bateman-House AU - Anna Maria Gerdina Pasmooij AU - Tim Yu AU - Matthis Synofzik AU - Julie Douville AU - Larissa Lapteva AU - Philip John Brooks AU - Daniel O’Connor AU - Annemieke Aartsma-Rus AU - Unknown PY - 2024 JO - Nature Reviews Drug Discovery DO - 10.1038/s41573-024-01059-3 UR - https://doi.org/10.1038/s41573-024-01059-3 ER -
APA
Jonker, A. H., Tataru, E., Graessner, H., Dimmock, D., Jaffe, A., Baynam, G., Davies, J., Mitkus, S., Iliach, O., Horgan, R., Augustine, E. F., Bateman-House, A., Pasmooij, A. M. G., Yu, T., Synofzik, M., Douville, J., Lapteva, L., Brooks, P. J., O’Connor, D., Aartsma-Rus, A., & Unknown (2024). The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap. Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-024-01059-3
Source records
- crossref · retrieved 2026-09-26T07:39:03.012Z